Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxcyte, Inc.

45.28
+0.53001.18%
Post-market: 45.280.00000.00%16:31 EDT
Volume:1.39M
Turnover:62.50M
Market Cap:5.88B
PE:-10.97
High:45.36
Open:44.30
Low:43.78
Close:44.75
52wk High:116.00
52wk Low:27.66
Shares:129.82M
Float Shares:116.97M
Volume Ratio:1.17
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1261
EPS(LYR):-3.8028
ROE:-21.65%
ROA:-16.44%
PB:1.91
PE(LYR):-11.91

Loading ...

Guggenheim Remains a Buy on Vaxcyte (PCVX)

TIPRANKS
·
Oct 24

U.S. RESEARCH ROUNDUP- Equifax, Johnson & Johnson, Morgan Stanley

Reuters
·
Oct 16

Will Vaxcyte’s (PCVX) Manufacturing Expansion Deal Reinforce Its Long-Term Competitive Position?

Simply Wall St.
·
Oct 05

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Benzinga
·
Sep 30

Vaxcyte - on Sept 24, Co Entered Agreement With Patheon Manufacturing Services Llc, Part of Thermo Fisher - SEC Filing

THOMSON REUTERS
·
Sep 30

Vaxcyte to establish fill-finish manufacturing in North Carolina

TIPRANKS
·
Sep 30

Vaxcyte Announces $1 Billion Fill-Finish Manufacturing Agreement with Thermo Fisher in North Carolina

Reuters
·
Sep 30

Vaxcyte Initiated at Neutral by Goldman Sachs

Dow Jones
·
Sep 12

Vaxcyte initiated with a Neutral at Goldman Sachs

TIPRANKS
·
Sep 12

Vaxcyte Advances Vax-31 Infant Phase 2 Dose-Finding Study With First Participants Receiving Vax-31 Optimized Dose

THOMSON REUTERS
·
Sep 03

Vaxcyte: Intends to Release Topline Data From Primary Immunization Series & Booster Dose Either Sequentially or Together by End of H1 2027

THOMSON REUTERS
·
Sep 03

Vaxcyte Inc. Advances Phase 2 Study of VAX-31 Optimized Dose for Infants, Targeting Broad-Spectrum Protection Against Pneumococcal Disease

Reuters
·
Sep 03

Vaxcyte Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 07

Vaxcyte Q2 EPS $(1.22) Misses $(1.17) Estimate

Benzinga
·
Aug 07

Vaxcyte Q2 Operating Expenses USD 226.219 Million

Reuters
·
Aug 07

Cargo Therapeutics Inc. Assigns Lease to Dren Bio Management, Inc., Exploring Strategic Alternatives

Reuters
·
Jul 02

Vaxcyte Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 18

Stock Track | Vaxcyte (PCVX) Soars 5.14% Following Needham Analyst's Buy Rating

Stock Track
·
May 08

Vaxcyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Vaxcyte Q1 EPS $(1.04) Beats $(1.11) Estimate

Benzinga
·
May 08